Mirae Asset Global Investments
GOSS icon

Mirae Asset Global Investments’s Gossamer Bio GOSS Stock Holding History

Mirae Asset Global Investments’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73K Sell
131
-20
-13% -$447 ﹤0.01% 1655
2026
Q1 		$3.97K Buy
151
+10
+7% +$1.26K ﹤0.01% 1536
2025
Q4 		$34.9K Buy
+141
New +$32.2K ﹤0.01% 1469
2022
Q4 		– Sell
-348
Closed -$334K – 2557
2022
Q3 		$334K Buy
348
+104
+43% +$103K ﹤0.01% 2113
2022
Q2 		$163K Buy
+244
New +$151K ﹤0.01% 2204

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Mirae Asset Global Investments's GOSS Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Gossamer Bio (GOSS) stake by 13% in Q2 2026, selling an estimated $447 and leaving 131 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1655.

Mirae Asset Global Investments first reported a position in GOSS in Q2 2022 and has held it in 5 quarters since. The position peaked at $334K in Q3 2022. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Mirae Asset Global Investments held 131 shares of Gossamer Bio worth $1.73K as of Q2 2026.
  • Mirae Asset Global Investments sold 20 Gossamer Bio shares in Q2 2026, an estimated $447.
  • Gossamer Bio made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1655 holding.
  • Mirae Asset Global Investments first reported a position in Gossamer Bio in Q2 2022 and has held it in 5 quarters since.
  • Mirae Asset Global Investments's Gossamer Bio position peaked at $334K in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.